Clinical Trials · NCT00393380
Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- The Emmes Company, LLC
- Enrollment
- 13
- Start date
- Sep 2006
- Locations
- 4 sites, United States
- Primary endpoint
- Median Time to Neutrophil Engraftment (Defined as an Absolute Neutrophil Count [ANC] Greater Than 500)